That is bullshit and the FDA stated as much. The FDA's problem was with manufacturing procedures not being tight enough to prevent possible deviations in drug spec. Every drug they tested in teh US came back within specification. Stop spreading false lies about Ranbaxy. The company has enough problems without douche bags like you spreading more crap.
You must be on MMS's payroll or one of his puppets. You have ignored the fact that the FDA criminal investigation is continuing. You also seem to be unaware of the reports Ranbaxy has received from people using some of its products that those products were subpotent or not potent. Without testing every single capsule no one can say whether Ranbaxy has sold Sotret that is out of spec -- but we all know enough not to trust anything Ranbaxy does.
Nothing taken by anyone in the US has ever been subpotent or a placebo, and I challenge you to find one instance, or one US patient with an adverse event related to a Ranbaxy drug. i dare you.
Your statement is ridiculous--there is no way you can you prove it unless you have tested every dosage form Ranbaxy has sold in the US. Your challenge is equally ridiculous and you obviously don't know anything about pharmaceuticals. Every manufacturer receives reports of adverse events related to its products and most often it cannot be proven why the AE occured. You also should know that no one outside of Ranbaxy and the FDA criminal division has access to the data needed to determine how many people have reported problems with Ranbaxy's products. And that assumes Ranbaxy has properly retained and reported to the FDA all AE reports it has received -- a very big assumtion based on Ranbaxy's history of fraud. No one is able to test the pharmaceutical products they take so they have to trust that the products have been developed and manufactured properly --only a fool would trust Ranbaxy's products.
To paraphrase Yogi Berra....nobody is never going to prove nothing. What the FDA has found is akin to health inspectors discovering that a restaurant has been operating under unhygienic conditions. Nobody has fallen sick yet from eating there but because the kitchen is filthy, it is only a matter of time that someone will. This import ban is like health inspectors suspending the restaurant's license until conditions in the kitchen improve to comply with regulations. Ranbaxy being Ranbaxy, is spending money and energy on trying to disprove or discredit the inspection report instead of cleaning up its act. Of course, the other FDA-DoJ investigation on fraudulent clinical data and sub- or extra-potent drugs is a different matter altogether. That's like you ordering a mildly spiced chicken tikka masala but being served a fire-hot chicken vindaloo instead. But both the waiter and manager insist it is the former!
Ummm.......Well.......I know that Drug Safety gets AE reports as every drung on the market, no matter what company has them.....and I know that Ranbaxy is being sued for IBD associated with Sotret......so, that would equate to *at least* one adverse event, no?
Dude, Roche is being sued for IBS, so any other company that makes the drug will also be sued. NOT JUST RANBAXY. At least Sotret worked, unlike claravis, which may have the same active ingredient, but the fillers, etc made it less effective. IN MY OPINION,
Hey, SOTRET IS BACK!!!! ok, just kidding WTF is going on with the derm contract now that they are selling old old stuff??
Yes he is!! And I miss that little Pashtoon so much!! I may re-apply to the company. It's all true- Pashtoon's have "magic" tongues!! I want that Indian brave!!
